Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Poland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20083
20101
20134
20142
20151
20211
20225
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting3
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
SOTIO a.s.3
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
AbbVie (prior sponsor, Abbott)1
Bayer1
Corcept Therapeutics1
EMD Serono1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms21
Carcinoma, Ovarian Epithelial3
Colorectal Neoplasms3
Endometrial Neoplasms3
Fallopian Tube Neoplasms3
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Cholangiocarcinoma2
Peritoneal Neoplasms2
Stomach Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.